Effective strategy for prenatal prediction of Duchenne and Becker muscular dystrophy.

PubWeight™: 2.08‹?› | Rank: Top 2%

🔗 View Article (PMID 2890901)

Published in Lancet on December 05, 1987


S M Forrest1, T J Smith, G S Cross, A P Read, N S Thomas, R C Mountford, P S Harper, R T Geirsson, K E Davies

Author Affiliations

1: Nuffield Department of Clinical Medicine, John Radcliffe Hospital, Oxford.

Articles citing this ↘

The molecular basis for Duchenne versus Becker muscular dystrophy: correlation of severity with type of deletion. Am J Hum Genet (1989) 5.09

Intragenic deletions in 21 Duchenne muscular dystrophy (DMD)/Becker muscular dystrophy (BMD) families studied with the dystrophin cDNA: location of breakpoints on HindIII and BglII exon-containing fragment maps, meiotic and mitotic origin of the mutations. Am J Hum Genet (1988) 2.65

Duplicational mutation at the Duchenne muscular dystrophy locus: its frequency, distribution, origin, and phenotypegenotype correlation. Am J Hum Genet (1990) 2.20

Molecular and phenotypic analysis of patients with deletions within the deletion-rich region of the Duchenne muscular dystrophy (DMD) gene. Am J Hum Genet (1989) 2.12

Germinal mosaicism increases the recurrence risk for 'new' Duchenne muscular dystrophy mutations. J Med Genet (1989) 2.11

Demand for DNA probe testing in three genetic centres in Britain (August 1986 to July 1987). J Med Genet (1989) 1.95

Screening for Duchenne muscular dystrophy. Arch Dis Child (1989) 1.78

Becker muscular dystrophy: correlation of deletion type with clinical severity. J Med Genet (1990) 1.50

Normal human genomic restriction-fragment patterns and polymorphisms revealed by hybridization with the entire dystrophin cDNA. Am J Hum Genet (1988) 1.41

Early diagnosis and secondary prevention of Duchenne muscular dystrophy. Arch Dis Child (1989) 1.30

Evidence for mutation by unequal sister chromatid exchange in the Duchenne muscular dystrophy gene. Am J Hum Genet (1989) 1.17

Molecular genetics in clinical practice: evolution of a DNA diagnostic service. BMJ (1988) 1.11

Screening of deletions in the dystrophin gene with the cDNA probes Cf23a, Cf56a, and Cf115. J Med Genet (1990) 1.03

Duchenne muscular dystrophy in Wales: impact of DNA linkage analysis and cDNA deletion screening. J Med Genet (1989) 1.02

Molecular genetics as a diagnostic service. J Med Genet (1989) 0.96

Prenatal diagnosis of Duchenne muscular dystrophy: a three-year experience in a rapidly evolving field. J Inherit Metab Dis (1989) 0.84

Deletion patterns of Duchenne and Becker muscular dystrophies in Greece. J Med Genet (1995) 0.80

X linked or autosomal recessive? A new approach to an old problem. J Med Genet (1989) 0.75

2015 William Allan Award Introduction: Kay E. Davies. Am J Hum Genet (2016) 0.75

Articles by these authors ⇆

Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature (1982) 11.57

Possible prevention of neural-tube defects by periconceptional vitamin supplementation. Lancet (1980) 10.23

Interferon alfa-2b adjuvant therapy of high-risk resected cutaneous melanoma: the Eastern Cooperative Oncology Group Trial EST 1684. J Clin Oncol (1996) 9.68

Linkage analysis of two cloned DNA sequences flanking the Duchenne muscular dystrophy locus on the short arm of the human X chromosome. Nucleic Acids Res (1983) 8.92

Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature (1992) 8.85

A highly polymorphic DNA marker linked to adult polycystic kidney disease on chromosome 16. Nature (1985) 7.34

Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon. Cell (1990) 7.12

Cloning of a representative genomic library of the human X chromosome after sorting by flow cytometry. Nature (1981) 6.18

Relationship between trinucleotide repeat expansion and phenotypic variation in Huntington's disease. Nat Genet (1993) 5.70

Genetic diversity among Botulinum Neurotoxin-producing clostridial strains. J Bacteriol (2006) 4.75

Von Recklinghausen neurofibromatosis. A clinical and population study in south-east Wales. Brain (1988) 4.69

High- and low-dose interferon alfa-2b in high-risk melanoma: first analysis of intergroup trial E1690/S9111/C9190. J Clin Oncol (2000) 4.60

A genetic study of von Recklinghausen neurofibromatosis in south east Wales. I. Prevalence, fitness, mutation rate, and effect of parental transmission on severity. J Med Genet (1989) 4.42

The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating. Science (1986) 4.40

Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell (1997) 4.38

Analysis of deletions in DNA from patients with Becker and Duchenne muscular dystrophy. Nature (1986) 4.13

The nucleotide sequence of poliovirus type 3 leon 12 a1b: comparison with poliovirus type 1. Nucleic Acids Res (1983) 4.06

Further experience of vitamin supplementation for prevention of neural tube defect recurrences. Lancet (1983) 4.02

Hospital and physician volume or specialization and outcomes in cancer treatment: importance in quality of cancer care. J Clin Oncol (2000) 4.01

Comparison of the complete nucleotide sequences of the genomes of the neurovirulent poliovirus P3/Leon/37 and its attenuated Sabin vaccine derivative P3/Leon 12a1b. Proc Natl Acad Sci U S A (1984) 3.98

Forkhead transcription factor FKHR-L1 modulates cytokine-dependent transcriptional regulation of p27(KIP1). Mol Cell Biol (2000) 3.93

The three-dimensional structure of canine parvovirus and its functional implications. Science (1991) 3.87

The complete nucleotide sequence of a common cold virus: human rhinovirus 14. Nucleic Acids Res (1984) 3.85

Very mild muscular dystrophy associated with the deletion of 46% of dystrophin. Nature (1990) 3.84

SOX10 mutations in patients with Waardenburg-Hirschsprung disease. Nat Genet (1998) 3.82

Nucleocapsid and glycoprotein organization in an enveloped virus. Cell (1995) 3.66

Location and primary structure of a major antigenic site for poliovirus neutralization. Nature (1983) 3.64

Waardenburg's syndrome patients have mutations in the human homologue of the Pax-3 paired box gene. Nature (1992) 3.63

Actin-like filaments in the cleavage furrow of newt egg. Exp Cell Res (1971) 3.53

Genetic mapping of chronic childhood-onset spinal muscular atrophy to chromosome 5q11.2-13.3. Nature (1990) 3.48

Apparent prevention of neural tube defects by periconceptional vitamin supplementation. Arch Dis Child (1981) 3.45

2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol (2000) 3.38

Report of the committee on the genetic constitution of the X chromosome. Cytogenet Cell Genet (1989) 3.37

International SMA consortium meeting. (26-28 June 1992, Bonn, Germany). Neuromuscul Disord (1992) 3.26

Potent neutralization of botulinum neurotoxin by recombinant oligoclonal antibody. Proc Natl Acad Sci U S A (2002) 3.16

Prenatal diagnosis and carrier detection of Duchenne muscular dystrophy with closely linked RFLPs. Lancet (1985) 3.08

Telling the truth about terminal cancer. JAMA (1998) 3.07

Report of the Committee on the Genetic Constitution of the X and Y Chromosomes. Cytogenet Cell Genet (1985) 3.07

Human dystrophin expression in mdx mice after intramuscular injection of DNA constructs. Nature (1991) 3.03

Loss-of-function mutations in the cathepsin C gene result in periodontal disease and palmoplantar keratosis. Nat Genet (1999) 3.01

Waardenburg syndrome type 2 caused by mutations in the human microphthalmia (MITF) gene. Nat Genet (1994) 2.99

Clinical aspects of X-linked hypohidrotic ectodermal dysplasia. Arch Dis Child (1987) 2.95

Amelioration of the dystrophic phenotype of mdx mice using a truncated utrophin transgene. Nature (1996) 2.95

An autosomal transcript in skeletal muscle with homology to dystrophin. Nature (1989) 2.91

Phenotypic characterization of individuals with 30-40 CAG repeats in the Huntington disease (HD) gene reveals HD cases with 36 repeats and apparently normal elderly individuals with 36-39 repeats. Am J Hum Genet (1996) 2.88

The positions of three restriction fragment length polymorphisms on chromosome 4 relative to known genetic markers. Hum Genet (1984) 2.84

Frame-shift deletions in patients with Duchenne and Becker muscular dystrophy. Science (1988) 2.82

Chromosome-specific alpha satellite DNA from human chromosome 1: hierarchical structure and genomic organization of a polymorphic domain spanning several hundred kilobase pairs of centromeric DNA. Genomics (1987) 2.77

Further studies of gene deletions that cause Duchenne and Becker muscular dystrophies. Genomics (1988) 2.74

The prevention of Huntington's chorea. The Milroy lecture 1985. J R Coll Physicians Lond (1986) 2.74

Antiviral agent blocks breathing of the common cold virus. Proc Natl Acad Sci U S A (1998) 2.71

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68

Apparent prevention of neural tube defects by periconceptional vitamin supplementation. 1981. Int J Epidemiol (2011) 2.68

Preferential deletion of exons in Duchenne and Becker muscular dystrophies. Nature (1987) 2.67

Genetic risks for children of women with myotonic dystrophy. Am J Hum Genet (1991) 2.65

Deletions in the survival motor neuron gene on 5q13 in autosomal recessive spinal muscular atrophy. Hum Mol Genet (1995) 2.59

Toward a complete linkage map of the human X chromosome: regional assignment of 16 cloned single-copy DNA sequences employing a panel of somatic cell hybrids. Am J Hum Genet (1984) 2.58

Comparison of pregnancy outcome after amniocentesis for previous neural tube defect or raised maternal serum alphafetoprotein. Br J Obstet Gynaecol (1980) 2.50

Crystal structure of human rhinovirus serotype 1A (HRV1A). J Mol Biol (1989) 2.49

Fibroblasts as sentinel cells. Synthesis of chemokines and regulation of inflammation. Am J Pathol (1997) 2.47

Association of heart rate variability with occupational and environmental exposure to particulate air pollution. Circulation (2001) 2.46

Rabbit macrophage interferons. I. Conditions for biosynthesis by virus-infected and uninfected cells. J Exp Med (1967) 2.46

The use of linked DNA polymorphisms for genotype prediction in families with Duchenne muscular dystrophy. J Med Genet (1983) 2.45

Size of the unstable CTG repeat sequence in relation to phenotype and parental transmission in myotonic dystrophy. Am J Hum Genet (1993) 2.42

Factors influencing cosmetic outcome and complication risk after conservative surgery and radiotherapy for early-stage breast carcinoma. J Clin Oncol (1992) 2.42

Early-onset dystrophia myotonica. Evidence supporting a maternal environmental factor. Lancet (1972) 2.40

PDZ domains: targeting signalling molecules to sub-membranous sites. Bioessays (1997) 2.39

Control of cytomegalovirus retinitis using sustained release of intraocular ganciclovir. Arch Ophthalmol (1993) 2.39

A retrospective cohort study of lung cancer and diesel exhaust exposure in railroad workers. Am Rev Respir Dis (1988) 2.38

Unstable DNA sequence in myotonic dystrophy. Lancet (1992) 2.36

Physical mapping studies on the human X chromosome in the region Xq27-Xqter. Genomics (1987) 2.35

Huntington's Chorea in South Wales. A genetic and epidemiological study. Clin Genet (1981) 2.31

Structural analysis of a series of antiviral agents complexed with human rhinovirus 14. Proc Natl Acad Sci U S A (1988) 2.30

Hardy-Weinberg quality control. Ann Hum Genet (1999) 2.22

Consanguinity and complex cardiac anomalies with situs ambiguus. Arch Dis Child (1984) 2.21

Studies of a DNA marker (G8) genetically linked to Huntington disease in British families. Hum Genet (1986) 2.18

Genetic linkage between Becker muscular dystrophy and a polymorphic DNA sequence on the short arm of the X chromosome. J Med Genet (1983) 2.16

Molecular analysis and clinical correlations of the Huntington's disease mutation. Lancet (1993) 2.15

Exclusion testing for Huntington's disease in pregnancy with a closely linked DNA marker. Lancet (1987) 2.09

Adoption and genetic prediction for Huntington's disease. Lancet (1988) 2.09

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg (1993) 2.08

A case-control study of lung cancer and diesel exhaust exposure in railroad workers. Am Rev Respir Dis (1987) 2.07

Polycystic kidney disease re-evaluated: a population-based study. Q J Med (1991) 2.05

Linkage disequilibrium in Huntington's disease: an improved localisation for the gene. J Med Genet (1989) 2.05

Congenital myotonic dystrophy in Britain. I. Clinical aspects. Arch Dis Child (1975) 2.04

Correlation between fragment size at D4F104S1 and age at onset or at wheelchair use, with a possible generational effect, accounts for much phenotypic variation in 4q35-facioscapulohumeral muscular dystrophy (FSHD) Hum Mol Genet (1995) 2.02

Problems in genetic prediction for Huntington's disease. Lancet (1989) 2.00

Encephalopathy and fatty degeneratiof on the viscera in northeastern Thailand. Clinical syndrome and epidemiology. Pediatrics (1971) 2.00

DNA testing for fragile X syndrome in schools for learning difficulties. Arch Dis Child (1995) 1.98

Cardiac disease in myotonic dystrophy. Cardiovasc Res (1997) 1.98

The role of autolysins during vegetative growth of Bacillus subtilis 168. Microbiology (1998) 1.97

The complex nature of constitutional de novo apparently balanced translocations in patients presenting with abnormal phenotypes. J Med Genet (2005) 1.94

A pseudoautosomal gene in man. Science (1986) 1.94